Clinical trial
Memory Advancement by Intranasal Insulin in Type 2 Diabetes
NCT02415556 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Memory Advancement by Intranasal Insulin in Type 2 Diabetes
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 6, 2015
- Completion date
- May 31, 2020
- Enrollment
- 289 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus